A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. New tests have shown that the antibody is able to destroy myeloma cells.
A single antibody could be the key to treating multiple myeloma, or cancer of the blood, currently without cure or long-term treatment. New tests have shown that the antibody is able to destroy myeloma cells.